Central Nervous System Stroke Drug Pipeline Report Provides the User With Real Details on Stroke Drug Pipelines By Company and By Stage
Posted on: Thursday, 13 September 2007, 06:00 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68299) has announced the addition of "Central Nervous System - Stroke Drug Pipeline Report" to their offering.
"Central Nervous System - Stroke Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of stroke drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Contents:
Stroke Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Stroke Projects
--Top 20 companies in early stage Stroke Projects
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
For more information visit http://www.researchandmarkets.com/reports/c68299
Source: Life Science Analytics
Source: Business Wire
Related Articles
- Yamana Gold provides development and near development stage projects update
- Dustin Le Promoted to Vice President of Product Technology and Development at LINE-X(R) Franchise Development Company
- Pfizer Shows Accelerating Pipeline With Significant Growth in Late-Stage Clinical Development
- An Essential Study of Innovations and Pipelines for Respiratory Disorders: Discover Niche Markets, New Products and Future Developments
- First Uranium Provides Production and Project Development Update for the First Fiscal Quarter Ended June 30, 2008
- Minco Silver Wins Project Development Award
- Bechtel and Xstrata Copper Form Long-Term Strategic Partnership for Project Development
- GE Business Unit Grows in India With Stake in Investment Arm of KSK, Leading Indian Power Project Developer
- IBC Expands Coverage of Case Studies and Projects in Preclinical, Phase 1 and Phase 2
- Swagelok Company Names Director, Product and Market Development
 |
 |
User Comments (0)
RSS Feeds